Dedicated locality research platform
Enter your email address and you will receive
a link to reset your password
India’s billionaire “vaccine prince” Adar Poonawalla has agreed to buy a mansion in London for £138mn or Rs 1440 crore, the most expensive home sold this year in London. Aberconway House, a 25,000 square foot Mayfair mansion’s ‘Secret Gardens’, is nearly a century-old and is located near Hyde Park. It is currently owned by Dominika Kulczyk, daughter of the late businessman Jan Kulczyk, who was Poland’s richest man.
The impressive red-brick residence is named after Henry Duncan McLaren, Baron Aberconway, a turn-of-the-century industrialist who built the Grosvenor Square mansion.
The property will be acquired by Serum Life Sciences, a UK subsidiary of the Poonawalla family’s Serum Institute of India. As per reports, the house is meant to serve as a company guest house which is useful for hosting events donors tech partners and will help serum group in accessing global opportunities that were not possible from India.
Earlier this year, Indian billionaire Ravi Ruia, from the Essar Group, bought a Rs 1,200 crore (£113mn) London mansion in Regent’s Park linked to Russian property investor Andrey Goncharenko, in one of the UK capital’s biggest residential deals in recent years.
The Aberconway House deal is said to be the second-most expensive home ever sold in London. The most expensive residential transaction in London occurred in January 2020 when 2-8a Rutland Gate was sold for a record-breaking £210 million to Hui Ka Yan, the founder and chair of Evergrande.
Higher borrowing costs has impacted the UK housing market this year, because few buyers rely on mortgages. But the top end of London’s property market is insulated from this impact.
Trophy properties in London have remained attractive to international buyers despite new transparency measures brought in to help target Russian money after the war in Ukraine. And there is also a prospect of tax change if the Labour party wins the next UK general election.
Headquartered in Pune, Serum Institute is the world's biggest producer of vaccines. This London deal follows multimillion-pound investments in vaccine research and manufacturing facilities near Oxford. In 2021, the family pledged £50mn to Oxford university for a new Poonawalla Vaccines Research Building. The Serum Institute manufactures hundreds of millions of doses of the Oxford/AstraZeneca vaccine.
Adar Poonawalla is the Chief Executive Officer (CEO) of the Serum Institute of India (SII), a private family-owned business founded in 1966 by his father Dr Cyrus Poonawalla. Adar joined SII in 2001 and he focused on the company’s international market and ensuring new products were licensed and pre-qualified by the World Health Organization for supply to United Nations Agencies including UNICEF and PAHO. He took over from his father as CEO in 2011, taking complete control of day-to-day operations of the company.
Propscience is India’s dedicated property news portal. We cover the latest events, news, trends, deals, new launches and more.
All our services and tools are completely free of cost and available 24X7!
We use cookies to give you the best possible service while using our website, please click accept and carry on browsing if you're happy with this. For more information see our Privacy Policy.
Okay, Got it!This disclaimer ("Disclaimer") is applicable to the entire Site. Upon entering the Site it is recommended that you immediately read the Terms and Conditions and Privacy Policy listed therein. Your continued usage of this Site will indicate your unconditional acceptance of the said Terms and Conditions and Privacy Policy. You hereby agree that Propscience reserves the right to modify at any time, the Terms and Conditions and Privacy Policy governing this Site without prior notification. Your usage of the Site implies that you will be bound by any such modification. You agree and acknowledge that it is your responsibility to periodically visit the Site and stay updated with the Terms and Conditions and Privacy Policy of the Website.
The information contained in this Site has been provided by Propscience for information purposes only. This information does not constitute legal, professional or commercial advice. Communication, content and material within the Site may include photographs and conceptual representations of projects under development. All computer-generated images shown on the Site are only indicative of actual designs and are sourced from third party sites.
The information on this Site may contain certain technical inaccuracies and typographical errors. Any errors or omissions brought to the attention of Propscience will be corrected as soon as possible. The content of this Site is being constantly modified to meet the terms, stipulations and recommendations of the Real Estate Regulation Act, 2016 ("RERA") and rules made thereunder and may vary from the content available as of date. All content may be updated from time to time and may at times be out of date. Propscience accepts no responsibility for keeping the information in this website up to date or any liability whatsoever for any failure to do so.
While every care has been taken to ensure that the content is useful, reliable and accurate, all content and information on the Site is provided on an "as is" and "as available" basis. Propscience does not accept any responsibility or liability with regard to the content, accuracy, legality and reliability of the information provided herein, or, for any loss or damage caused arising directly or indirectly in connection with reliance on the use of such information. No information given under this Site creates a warranty or expands the scope of any warranty that cannot be disclaimed under applicable law.
This Site provides links to other websites owned by third parties. Any reference or mention to third party websites, projects or services is for purely informational purposes only. This information does not constitute either an endorsement or a recommendation. Propscience accepts no responsibility for the content, reliability and information provided on these third-party websites. Propscience will not be held liable for any personal information of data collected by these third parties or for any virus or destructive properties that may be present on these third-party sites.
Your use of the Site is solely at your own risk. You agree and acknowledge that you are solely responsible for any action you take based upon this content and that Propscience is not liable for the same. All details regarding a project/property provided on this Site are updated on the basis of information available from the respective developers/owners/promoters. All such information will not be construed as an advertisement. To find out more about a project / development, please register/contact us to visit the site you are interested in. All decisions taken by you in this regard will be taken independently and Propscience will not be liable for any such loss in connection with the same. This Site is for guidance only. Your use of this Site - including any suggestions set out in the Site and or any use of the resources available on this Site, do not create any professional - client relationship between you and Propscience. Propscience cannot accept you as a client until certain formalities and requirements are met.
We use cookies to give you the best possible service while using our website, please accept it and continue browsing if you're happy with this. For more information see our Privacy Policy